{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022954","form_type":"8-K","ticker":"NORD","cik":"0001011060","company_name":"Nordicus Partners Corp","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.123012+00:00","generated_at":"2026-05-17T15:06:33.030121+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Nordicus Partners furnishes independent valuations for Orocidin and Bio-Convert subsidiaries","bullets":["Stanton Park Advisors LLC prepared valuation reports for Orocidin's QR-01 and Bio-Convert's QR-02 as of June 30, 2025.","The valuations are intended for Board evaluation of fair market value and should not be relied upon for other purposes.","No specific valuation figures are disclosed in the filing; exhibits are placeholders only."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022954","json":"https://secwatch.observer/filing/0001641172-25-022954.json","markdown":"https://secwatch.observer/filing/0001641172-25-022954.md","text":"https://secwatch.observer/filing/0001641172-25-022954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/0001641172-25-022954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:06:33.030121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}